Economy

Markets

Industries

Insights

Reports

Events

DSM acquires share in Chinese pharmaceutical company NCPC

(Xinhua)
Updated: 2009-03-20 16:24

Dutch chemical manufacturer DSM has acquired a 9.77 percent share in North China Pharmaceutical Group Corporation (NCPC) of Shijiazhuang, Hebei province, an official with the NCPC said Friday.

Related readings:  DSM, Dow still bullish on expansion  Drug maker Sanjiu's profits surge 87% in 2008  Pharma stocks offer new hope

The official said DSM, NCPC and its Shanghai-listed subsidiary NCPC Ltd signed the investment contracts Thursday.

DSM spent 827 million yuan ($121.1 million) for the share in the NCPC and will set up three joint ventures with NCPC Ltd.

The NCPC Ltd will hold a 70 percent share in the nutrition production joint venture and 49 percent in the two antibiotic joint ventures, the official said.

The DSM said on its website that the investment will leverage its technology and management capabilities, while the NCPC will bring to the joint ventures its existing factories, which produce Vitamin C and beta lactam antibiotics, as well marketing and sales force.

"The overall strategic partnership with NCPC provides an accelerated growth into the Chinese market and will contribute to our target of $1.5-billion-sales in China in 2010," Jan Zuidam, DSM's deputy chairman of the managing board, as quoted by the website.

DSM, headquartered in the Netherlands and listed on Euronext Amsterdam, has annual sales of almost 8.8 billion euros ($12 billion) and employs some 23,000 people worldwide. Its sales in China was $1.151 billion last year.

NCPC employs 18,500 people and achieved $877 million in domestic and export sales.